Antitumor activity of sphingosine kinase inhibitors.

The Journal of Pharmacology and Experimental Therapeutics
Kevin J FrenchCharles D Smith

Abstract

Sphingosine kinase (SK) is an oncogenic sphingolipid-metabolizing enzyme that catalyzes the formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) at the expense of proapoptotic ceramide. Thus, SK is an attractive target for cancer therapy because blockage of S1P formation leads to inhibition of proliferation, as well as the induction of apoptosis in cancer cells. We have recently identified novel SK inhibitors with nanomolar to low micromolar potencies toward recombinant human SK. This study describes the continuing analysis of these inhibitors through in vitro and in vivo experiments. All three structurally diverse SK inhibitors tested showed antitumor activity in mice without exhibiting toxicity. Blood and tumor inhibitor concentrations exceeded in vitro potency levels. Cell signaling analyses in vitro revealed mixed inhibition of mitogen-activated protein kinase kinase and Akt phosphorylation by the SK inhibitors. Importantly, 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) is orally bioavailable, detected in the blood for at least 8 h, and showed a significant inhibition of tumor growth in mice. These compounds are the first examples of nonlipid selective inhibitors of SK with in vivo antitumor...Continue Reading

References

Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Nov 22, 1995·Biochemical and Biophysical Research Communications·T MegidishS Hakomori
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·P XiaM A Vadas
Feb 12, 2000·Prostaglandins, Leukotrienes, and Essential Fatty Acids·L C CarpioR Dziak
Apr 5, 2000·The Journal of Biological Chemistry·C C KingG M Bokoch
Jul 6, 2000·The Biochemical Journal·S Pyne, N J Pyne
Dec 15, 2000·Current Biology : CB·P XiaM A Vadas
Mar 10, 2001·Journal of Neurochemistry·L C EdsallS Milstien
Jun 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y OsawaH Moriwaki
Aug 25, 2001·Biochemical and Biophysical Research Communications·Y OsawaS Nakashima
Sep 22, 2001·Endocrine-related Cancer·J F LyonsG Bollag
Jan 5, 2002·The Journal of Biological Chemistry·Pu XiaMathew A Vadas
Jan 30, 2002·The Journal of Biological Chemistry·Lewis R VannSheldon Milstien
Nov 21, 2002·Experimental Cell Research·Victor E NavaSarah Spiegel
Dec 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Nathalie AugeAnne Negre-Salvayre
May 3, 2003·Nature Reviews. Molecular Cell Biology·Sarah Spiegel, Sheldon Milstien
May 15, 2003·The Journal of Biological Chemistry·Kiyoshi Itagaki, Carl J Hauser
May 31, 2003·Oncogene·Weicheng WuDaniel Broek
Jun 6, 2003·Cellular and Molecular Life Sciences : CMLS·R ChihabT Andersson
Jul 2, 2003·Journal of Neuroscience Research·Israel Ramos VillullasPeter B Simpson
Jul 26, 2003·Molecular Endocrinology·Olga A SukochevaPu Xia
Oct 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hans M RosenfeldtSarah Spiegel
Oct 9, 2003·The EMBO Journal·Stuart M PitsonBinks W Wattenberg
Jan 20, 2004·Biochimica Et Biophysica Acta·Yusuke NakadeTakashi Murate

❮ Previous
Next ❯

Citations

Dec 7, 2006·Archives of Pharmacal Research·You-Xun JinYong-Moon Lee
Jul 15, 2009·Cancer Chemotherapy and Pharmacology·Meryem BektasHenry S Friedman
May 18, 2010·Investigational New Drugs·Vladimir BeljanskiCharles D Smith
Feb 13, 2010·Inflammopharmacology·Lynn W MainesCharles D Smith
Oct 12, 2010·Inflammopharmacology·Leo R FitzpatrickCharles D Smith
Sep 10, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Johannes Rolin, Azzam A Maghazachi
Jun 18, 2010·Nature Reviews. Cancer·Nigel J Pyne, Susan Pyne
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Matthias P Wymann, Roger Schneiter
Feb 8, 2013·Chemical Communications : Chem Comm·Dong Jae BaekRobert Bittman
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ranran ZhangThomas P Loughran
Dec 29, 2009·Assay and Drug Development Technologies·Jolanta VidugirieneSaid A Goueli
Mar 23, 2013·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Lars Christian HankerKnut Engels
May 20, 2011·Pigment Cell & Melanoma Research·Yongmei FengGary G Chiang
Jan 13, 2012·Pigment Cell & Melanoma Research·SubbaRao V MadhunapantulaGavin P Robertson
Feb 25, 2010·The Journal of Pharmacology and Experimental Therapeutics·Vladimir BeljanskiCharles D Smith
Jan 12, 2010·The Journal of Pharmacology and Experimental Therapeutics·Kevin J FrenchCharles D Smith
Jun 17, 2008·Pharmacological Reviews·Kazuaki TakabeSarah Spiegel
Sep 24, 2011·Cancer Research·Susan PyneNigel J Pyne
Jul 18, 2009·Molecular Cancer Research : MCR·Kristin GustafssonJenny Flygare
Sep 8, 2011·Molecular Cancer Research : MCR·Peng Gao, Charles D Smith
Jul 8, 2010·Cells, Tissues, Organs·María M FacchinettiAlejandro C Curino
Oct 8, 2011·Stroke; a Journal of Cerebral Circulation·Lai Ming YungChristian Waeber
Nov 9, 2011·BMC Cancer·Aintzane ApraizAintzane Asumendi
Mar 17, 2010·Journal of Lipid Research·Max SchererGerhard Liebisch
Dec 4, 2008·Future Lipidology·Erhard Bieberich
Jun 28, 2014·Biomolecules·Anthony S DonTimothy A Couttas
Jan 5, 2014·Biochimica Et Biophysica Acta·Jean-Philip TrumanYusuf A Hannun
Jan 24, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Regina AlemanyDagmar Meyer Zu Heringdorf
Dec 7, 2007·Breast Cancer Research and Treatment·Eugen RuckhäberleManfred Kaufmann
Feb 16, 2011·Journal of Molecular Endocrinology·James W AntoonBarbara S Beckman
Jan 15, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Long Shuang HuangViswanathan Natarajan
Dec 7, 2007·Digestive Diseases and Sciences·Lynn W MainesCharles D Smith
Apr 20, 2010·Journal of Cancer Research and Clinical Oncology·Zeynep CakirYusuf Baran
Jul 16, 2008·Expert Opinion on Therapeutic Targets·Olivier Cuvillier
Mar 26, 2010·Expert Opinion on Therapeutic Targets·Thomas H BeckhamXiang Liu
Apr 5, 2011·Expert Opinion on Therapeutic Patents·Arun K Sharma
Sep 15, 2006·FEBS Letters·Besim Ogretmen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.